Keloids, partially considered as benign tumors, represent the most extreme example of cutaneous scarring that uniquely afflicts humans as a pathological response to wound healing. It is characterized by excessive deposition of collagen and other extracellular matrix components by dermal fibroblasts. Upon cutaneous injury, cocktails of chemokines, cytokines and growth factors are secreted temporally and spatially to direct appropriate responses from neutrophils, macrophages, keratinocytes and fibroblasts to facilitate normal wound healing. Signal transducer and activator of transcription 3 (Stat3) is an oncogene and a latent transcription factor activated by various cytokines and growth factors. We investigated the possible role of Stat3 in keloid scar pathogenesis by examining skin tissue and cultured fibroblasts from keloid-scarred patients. We observed enhanced expression and phosphorylation of Stat3 in keloid scar tissue, and in cultured keloid fibroblasts (KFs) in vitro. Increased activation of Janus kinase (Jak)2, but not Jak1, was detected in KFs, and suppression of Jak2 by its inhibitor repressed Stat3 Y705 phosphorylation. Inhibition of Stat3 expression and phosphorylation by short interfering RNA or Cucurbitacin I resulted in the loss of collagen production, impaired proliferation and delayed cell migration in KFs. We show, for the first time, a role of Stat3 in keloid pathogenesis. Inhibitors of Stat3 may be useful therapeutic strategies for the prospective treatment of keloid scars.
Introduction
Wound healing is a regulated, yet complex, event including the breakdown of fibrin clots, degradation of extracellular matrix (ECM), promotion of angiogenesis, and the migration and proliferation of keratinocytes and fibroblasts. In the event of excessive wound healing scar formation occurs, ranging from hypertrophic scars to keloids. The term 'keloid' was coined in 1806 to describe the crab claw-like appearance of the scar (Yang et al., 2003) . Keloids are strictly defined as scars that spread beyond the boundaries of the original wound and do not regress spontaneously (Cosman et al., 1961) . In contrast, hypertrophic scars do not develop beyond the periphery of wound, with spontaneous softening and flattening from remodeling over time (Ragoowansi et al., 2001) . These scars afflict humans exclusively, and the inciting skin trauma can range from small injuries such as ear piercing and abrasions to more severe trauma such as surgery or burns.
Keloids are aggressive in nature and Africans and Asians appear to be more susceptible (Tuan and Nichter, 1998) . Treatment and management of keloid scars have been difficult, owing to their recurrence, and although a myriad of treatments are available none are fully effective (Tuan and Nichter, 1998; Alster and Tanzi, 2003; Mustoe, 2004) . Keloid scars are typified by overexuberant deposition of collagen and other ECM components such as fibronectin by keloid fibroblasts (KFs) (Diegelmann et al., 1979; Babu et al., 1989) , with overproduction of collagen types I and III mRNA in keloid tissues (Naitoh et al., 2001) . Keloid fibroblasts reportedly displayed an increased rate of proliferation upon wounding (Calderon et al., 1996) . At the cellular level, increased levels of cytokines and growth factors, or their receptors, and sensitization of mitogenic response to these secreted factors after wounding in KFs have been suggested to play a role in keloid pathogenesis (Calderon et al., 1996) . Transforming growth factor (TGF)-b1 and TGF-b2 were found to be elevated in KFs (Lee et al., 1999) , and increased sensitivity to TGF-b1 in KFs increased fibronectin (Babu et al., 1992) and collagen production, and cell proliferation (Younai et al., 1994) . Platelet-derived growth factor (PDGF)a receptor expression was shown to be enhanced in KFs, which corresponded to increased mitotic response upon exposure to all three PDGF isoforms (Haisa et al., 1994) . Overexpression of insulinlike growth factor-I receptor detected in KFs appeared to enhance their invasiveness, but not fibroproliferation (Yoshimoto et al., 1999) . Elevated interleukin (IL)-6 (Xue et al., 2000) and vascular endothelial growth factor (Wu et al., 2004) expression have also been observed in KFs.
Signal transducer and activator of transcription 3 (Stat3) is an oncogene and a latent transcription factor that is involved in diverse processes, including cell proliferation and migration, inflammation, immune response and cell survival. It is activated by various growth factors and cytokines, including PDGF and IL-6 (Darnell, 1997) , by Tyr705 phosphorylation, which enables the dimerization via its phosphotyrosine residue and reciprocal SH2 domain of its dimer partner. Stat3 can homodimerize, or heterodimerize with Stat1, and the dimer then translocates to the nucleus, binds to target DNA sequences and regulates the transcription of target genes (Darnell et al., 1994) . Whereas Tyr705 phosphorylation is essential for Stat3 activation, Ser727 phosphorylation was shown to be required for maximal gene activation (Wen et al., 1995) . Tyr705 phosphorylation in cytokine receptors that lack intrinsic tyrosine kinase activity is mediated by receptor-associated Janus kinases (Jaks) (Darnell, 1997) . Overexpression of a constitutively activated Stat3 caused cell transformation and tumorigenesis in mice (Bromberg et al., 1999) . Activation of Stat3 has been detected in various cancers and tumor-derived cell lines (reviewed by Bowman et al., 2000) . On the other hand, Stat3 knockout resulted in embryonic lethality (Takeda et al., 1997) , prompting further conditional tissue-or cell-specific knockout analyses (Takeda and Akira, 2000) . In particular, Stat3 expression disrupted in keratinocytes using Cre recombinase driven by keratin 5-specific promoter showed impaired wound healing and growth factor-dependent migration of Stat3-deficient epidermal cells in mice, although the development of epidermis and hair follicles appeared normal and proliferation remained unaffected (Sano et al., 1999) .
In this paper, we hypothesized a role for Stat3 in keloid scar pathogenesis as Stat3 was previously shown to function in wound healing (Sano et al., 1999) . Moreover, Stat3 is a key molecule activated by various cytokines and growth factors, ligands that are known to be secreted by various cell components in response to tissue injury during wound healing. Our results showed an enhancement of Stat3 expression and/or phosphorylation in keloid tissues in vivo, as well as in cultured proliferating KFs. We detected concomitant increased activation of Jak2, but not Jak1, in KFs compared to normal dermal fibroblasts. Inhibition of Tyr705 Stat3 phosphorylation was observed by Jak2 inhibitor, AG 490, corroborating our hypothesis that Jak2 mediates Stat3 phosphorylation. Finally, we demonstrated that the increased collagen production, cell proliferation and migration in KFs were suppressed by Stat3 short interfering RNA (siRNA) and an inhibitor of Jak2/Stat3, Cucurbitacin I (Blaskovich et al., 2003) . Taken together, these data reveal an important role of Stat3 in the pathogenesis of keloid scars. Stat3 inhibition suppresses KF activity, and may serve as a therapeutic target for the treatment of keloid fibrosis.
Results
Enhanced Stat3 expression and phosphorylation in keloid scar tissue vs normal skin tissue in vivo A thin layer of epidermis underlies a very thin layer of keratin in normal skin. In contrast, the keratin and epidermal layers of keloid tissue are thicker, as shown by the hematoxylin-eosin staining of paraffin sections (Figure 1a) . The dermis is also considerably thicker, with compacted and irregular connective tissue compared to normal skin, which appears more uniformly stacked and regular.
To examine the expression of Stat3, cryosections from normal skin and skin overlying keloid scar were subjected to immunofluorescence using a polyclonal Stat3 (C-20) antibody, performed in parallel with antirabbit immunoglobulin (Ig)G as controls. As illustrated in Figure 1b , Stat3 could be detected in both normal skin and keloid tissue, whereas weak fluorescence was observed with anti-rabbit IgG antibody. Stat3 expression was easily detected in the epidermal layer in both skin types, which is predominantly populated with keratinocytes. In the dermal layer, the connective tissue is interspersed with cellular components comprised primarily of fibroblasts, which are involved in the deposition of collagen fibers and other ECM components. A small population of fibroblast cells in the dermal layer of normal skin also showed Stat3 expression, whereas a much higher number of fibroblasts in keloid samples 25, 26, 31 and 48 showed Stat3 expression ( Figure 1b and data not shown).
Activation of Stat3 was also examined using phosphoStat3 (pStat3) monoclonal antibody, performed in parallel with anti-mouse IgG as controls. Weak pStat3 staining was observed in normal skin, whereas activation of Stat3 was significantly increased in both dermis and epidermis in keloid 26 (Figure 1c) .
To further verify the data above, tissue lysates of normal skin from five individuals and keloid scars from eight individuals were investigated for phosphorylation and expression of Stat3. Three samples from normal skin showed low Tyr705 Stat3 phosphorylation, whereas two showed moderate Tyr705 Stat3 phosphorylation (Figure 1d ). In contrast, all keloid tissue lysates, except for one, showed moderate to very high Tyr705 Stat3 phosphorylation. The degree of Tyr705 Stat3 phosphorylation correlated well with the level of Stat3 expression. As for Ser727 Stat3 phosphorylation, six out of eight keloid tissue samples showed an increase in Ser727 Stat3 phosphorylation compared to all five normal skin samples.
Increased Stat3 activation in keloid fibroblasts compared to normal skin fibroblasts The epidermis is populated with 95% keratinocytes and 5% non-keratinocyte cells comprising melanocytes, Langerhans cells and Merkel cells (Edmondson et al., 2003) , whereas fibroblasts are the predominant cells in the dermis, along with some endothelial and mast cells. As we observed increased Tyr705 Stat3 phosphorylation in the dermal cells in keloid tissue compared to normal skin, we further investigated the activation of Stat3 in primary fibroblast cells derived from normal skin and keloid tissues. Two normal fibroblast (NF) and three KF strains were examined for Stat3 activation. Tyr705 phosphorylation of Stat3 was elevated from 2.3-to 4.3-fold, with an average of three-fold, in KFs compared to NFs (Figure 2a ). Tyr phosphorylation of Stat1 and Stat5 was also examined, but was undetectable in any of the samples. Signal transducers and activators of transcription 1 protein expression was present, whereas Stat5 expression was weak, in all of the samples.
To further examine the kinetics of Tyr705 and Ser727 Stat3 phosphorylation, NFs and KFs were cultured for 5 days under normal growth conditions. Five different sets of NF and KF were examined, and two are presented here as representatives. In NF5, very weak Tyr705 Stat3 phosphorylation was observed at day 1, increased at day 2 and sustained until day 5 (Figure 2b , left panel). In contrast, strong Tyr705 Stat3 phosphorylation was observed in KF48 at day 1, which increased from day 2 to day 4, and decreased to day 1 level at day 5. The Ser727 Stat3 phosphorylation profile was similar to Tyr705 Stat3 phosphorylation in both NF5 and KF48. In addition, an elevated Stat3 expression was observed in KF48 compared to NF5. This kinetics in NF5 and KF48 is similarly observed in NF4 and KF8 ( Figure 2b , right panel), and KF8 also showed an enhanced pY705 Stat3 and pS727 Stat3 compared to NF4.
Stat3 phosphorylation was further examined in serum-free condition. We observed strong constitutive Tyr705 and Ser727 Stat3 phosphorylation in KF48 throughout the 5 days, compared to very weak phosphorylation in NF4 (Figure 2c ). Although actin expression was similar in all samples, Stat3 expression was elevated in KF48 compared to NF4. Nevertheless, a dramatic increase in the Tyr705 Stat3 phosphorylation in KF48 was clearly observed after normalization to Stat3 expression. Overall, phosphorylations and expression of Stat3 were augmented in KFs and tissue lysates compared to the samples from normal skin. Tyr705 and Ser727 Stat3 phosphorylations in KFs also occur in a constitutive and serum-independent manner. Jak2, but not Jak1, activation is increased in keloid fibroblasts Janus kinase (Jak)1 and Jak2 are known Tyr kinases that phosphorylate Stat3 in cytokine signaling. We examined whether Jaks contribute to the enhanced pTyr705 Stat3 in KF. Nearly confluent NFs and KFs were maintained in serum-free media and harvested, and activation of endogenous Jak1 and Jak2 was examined in Western blot analysis using anti-phosphoJak1 (pJak1) or anti-phosphoJak2 (pJak2) antibody. As shown in Figure 3a , increased pJak2 was detected in KF48 compared to NF103, whereas pJak1 signal hardly detectable in either normal fibroblasts or KFs, although Jak1 expression was present in both cell types. We also examined Src and epidermal growth factor receptor (EGFR), as they are reported to be able to phosphorylate Stat3 also. However, phosphoSrc (Tyr416) and phosphoEGFR (Tyr845) signals were undetectable in both NF and KF (data not shown).
To confirm that Jak2 mediates Stat3 Tyr phosphorylation, NF103 and KF48 were incubated with tyrphostin AG 490, a Jak2 tyrosine kinase inhibitor. pTyr705 Stat3 was inhibited by AG 490, but not by dimethyl sulfoxide (DMSO) control, as shown in Figure 3b . This corroborates the finding that Jak2 mediates Tyr705 Stat3 phosphorylation in both normal and keloid skin fibroblasts. phosphorylation by Jak2, but not Jak1. Equal amounts of total cell lysates from normal fibroblast, NF103 and keloid fibroblast, KF48, were resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and Western blot analysis was performed using phosphoJak1 (pJak1) or phosphoJak2 (pJak2) antibodies. The blot was stripped and reprobed with Jak1 and Jak2 antibodies, respectively, and subsequently with anti-actin for normalization. Arrows indicate the position of the protein bands. (b) NF103 and KF48 were serum-starved for 24 h and incubated with either dimethyl sulfoxide (DMSO) or 50 mM AG 490 for another 27 h. Equal amounts of total cell lysates were resolved in SDS-PAGE and blotted with pY705 Stat3 antibody in Western blot analysis. The blot was stripped and reprobed with Stat3 and actin antibodies. and KF8, were cultured in serum-free media for 2 days before stimulating with 10% fetal bovine serum. Total cell lysates were harvested at day 1-5, and phosphorylations of Stat3 were analysed by Western blot after loading equal amounts of protein. (c) NF4 and KF48 fibroblasts were incubated in serum-free Dulbecco's modified Eagles's medium for 2 days before harvesting daily over 5 days to investigate the serum-independent phosphorylation of Stat3. Equal amounts of total cell lysates were subjected to Western blot analysis with antibodies as indicated. Arrowheads indicate the position of the protein bands.
Increased Stat3 phosphorylation and expression in keloid CP Lim et al Inhibition of Stat3 inhibits collagen production and Stat3 target genes Secretion of collagen by fibroblasts occurs during the process of tissue remodeling in wound healing, and enhanced collagen production has been implicated in fibrosis (Singer and Clark, 1999) . Indeed, collagen production was elevated in six out of eight keloid tissue samples examined, whereas the other two showed a similar expression to those from five normal skin samples (Figure 4a ).
To investigate whether Stat3 plays any role in keloid pathogenesis, KFs were infected with retrovirus expressing Stat3 siRNAs. Of the four different targets for Stat3 siRNA selected, three displayed an inhibitory effect on Stat3 expression, namely Stat3 siRNA 1, 2 and 4, but not Stat3 siRNA 3, in a 293T-based amphotropic packaging cell line (Figure 4b, left panel) . Inhibition of Stat3 expression by these three Stat3 siRNAs correlated with the inhibition of collagen production in KF48 (Figure 4b , right panel). Inhibition of Stat3 was also evaluated by incubating KF48 for 30 min with various doses of Cucurbitacin I, an inhibitor of Jak2/Stat3 activation (Blaskovich et al., 2003) , or with DMSO as a control, followed by further incubation in normal growth media for 48 h. As shown in Figure 4c , a dosedependent inhibition of pTyr705 Stat3 and collagen production was observed by Cucurbitacin I, with effective concentration as low as 1 mM. A dose-dependent decrease of Stat3 expression was also observed, although actin expression was rather similar in all samples. In addition, inhibition of Stat3 also resulted in a decreased expression of two Stat3 target genes (Bromberg et al., 1999) , cell cycle regulator cyclin D1 and antiapoptotic Bcl-X L (Figure 4c ). Taken together, inhibition of Stat3 resulted in diminished collagen production and Stat3 target genes.
Inhibition of Stat3 decreases cell proliferation
Enhanced fibroblast proliferation is a characteristic of keloid tissue. In agreement with this, KFs grown in normal culture conditions proliferated faster than NFs, as observed in KF48 and KF107 compared to NF2 and NF4 (Figure 5a ). To investigate whether Stat3 is involved in the enhanced KF proliferation, KF48 was infected with retrovirus expressing Stat3 siRNAs, and cell proliferation was examined. As shown in Figure 5b , inhibition of Stat3 by Stat3 siRNA 4 decreased cell proliferation of KF48, compared to a non-infected control, vector control and Stat3 siRNA 3, which do not inhibit Stat3. Cell proliferation was also investigated by treating KF48 cells with various doses of Cucurbitacin I or with DMSO control before incubating in normal growth media and examined daily over 4 days. Cucurbitacin I concentration as low as 1 mM was able to inhibit cell proliferation of KF48 compared to DMSO and untreated control (0 mM), whereas Cucurbitacin I exposure at 5 mM and above seemed to cause cell death (Figure 5c ).
Increased cell migration in keloid fibroblast
Wound healing is a complex multi-step process. It involves the migration and proliferation of keratinocytes and fibroblasts to resurface areas of skin loss. We further examined the migration potential of NFs and KFs using the scratch assay. Cells were first cultured to full confluence, and treated with 10 mg/ml mitomycin C for 2 h before scratch-wounding with a yellow pipette tip. Pictures were taken at 0 and 14 h later. As observed Equal amounts of total cell lysates were resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and examined for the phosphorylation and expression of Stat3, expression of cyclin D1, Bcl-X L , actin and production of collagen in Western blot analyses. Arrows/arrowheads indicate the position of the protein bands.
Increased Stat3 phosphorylation and expression in keloid
CP Lim et al in Figure 6a , all three NFs, NF2, NF4 and NF103, showed a slower migration pattern towards the midline of scratch wound compared to three KFs, KF43, KF48 and KF107. Three non-overlapping fields were captured and quantified as mean7s.d., and results are presented in Figure 6b . All three KF samples displayed enhanced cell migration rates compared to the three NF samples examined. Cell migration was also examined by the transmembrane assay using the 8.0 mM pore size polyvinylpropylene-free polycarbonate Transwell membranes, performed in triplicates. Three non-overlapping fields per replicate were captured and quantified as the mean of the total migrating cells in the triplicates. Once again, the three KF samples showed significant increased migration compared to the three NF samples (Figure 6c ).
Cell migration in keloid fibroblasts is inhibited by Stat3 short interfering RNA and Cucurbitacin I To examine the role of Stat3 in cell migration of skin fibroblasts, KF48 cells were infected with retrovirus expressing Stat3 siRNAs and scratch assays were performed as described previously. In Figure 7a , Stat3 siRNA 1, 2 and 4, all of which inhibit Stat3 expression, were able to impede cell migration of KF48, whereas vector alone or Stat3 siRNA 3, which did not inhibit Stat3 expression and served as a negative control, had no rescuing effect. Three non-overlapping fields were acquired, and graphically illustrated as mean7s.d. in Figure 7b . Transmembrane cell migration assays were also performed in triplicates as described earlier, and quantified as mean7s.d. (Figure 7c ). In agreement with the scratch assay, Stat3 siRNA 1, 2 and 4 were able to reduce the cell migration of KF48, whereas vector and Stat3 siRNA 3 did not. The right panels in Figure 7b and c depict immunoblots of Stat3 and actin to show the efficiencies of inhibition by the Stat3 siRNAs. The role of Stat3 in cell migration was also examined using Cucurbitacin I in the scratch assay. KF48 cells were first incubated with 10 mg/ml mitomycin C for 2 h, before treating for 30 min with DMSO or 1 mM Cucurbitacin I, the effective dose for inhibiting Stat3 activation as observed in Figure 4c . The scratch wounding was performed, followed by further incubation in normal growth media. Pictures were taken at 0, 22 and 48 h after wounding. As shown in Figure 7d , inhibition of Stat3 activation by Cucurbitacin I decelerated the migration of KF48, compared to DMSO control. Quantification of the mean7s.d. of three nonoverlapping fields is depicted in Figure 7e , and showed a significant reduction in cell migration at 22 h and a delayed migration at 48 h by Cucurbitacin I compared to DMSO control (*Po0.001). These results are in agreement with our recent report showing defective cell migration in Stat3-deficient mouse embryonic fibroblasts (Ng et al., 2006) .
Discussion
Keloid scars do not occur spontaneously, but are the result of excessive wound healing after cutaneous injuries, exhibiting abnormalities in cell migration, proliferation, inflammation, synthesis and secretion of collagen and other ECM components, and remodeling of the wound matrix (Singer and Clark, 1999) . In this paper, we investigated the role of Stat3 in keloid pathogenesis in both normal skin and keloid tissue Increased cell proliferation in keloid fibroblasts (KFs) compared to normal fibroblasts (NFs). Normal fibroblasts, NF2 and NF4 and KFs, KF48 and KF107, were seeded at 3000 cells/well in 96-well plates in quadruplicates in normal growth media, and cell proliferation was examined daily up to 6 days using XTT cell proliferation kit according to the manufacturer's instruction. (b) KF48 fibroblasts were seeded in 96-well plates, infected with retroviral Stat3 short interfering RNAs (siRNAs) the next day for 18 h, before changing to 10% fetal bovine serum (FBS)/Dulbecco's modified Eagles's medium (DMEM). Cell proliferation was examined daily from the day of infection. (c) KF48 fibroblasts were seeded in 96-well plates and either left untreated (0) or treated with dimethyl sulfoxide (DMSO) or various doses of Cucurbitacin I, and cell proliferation was examined daily over 4 days.
sections, as well as in fibroblast cell cultures. Our data showed that Stat3 expression and phosphorylation are enhanced in keloid tissue sections, tissue lysates and fibroblasts (Figures 1b-d and 2) , and Stat3 Tyr phosphorylation is mediated by Jak2 (Figure 3) . Inhibition of Stat3 using Stat3 siRNA or by an inhibitor of Jak2/Stat3 activation, Cucurbitacin I, decreased the collagen production, proliferation and migration of KFs, to a level comparable to that of NFs (Figures 4-7) .
Fibroblasts are responsible for the synthesis, deposition and remodeling of the ECM. We report here that overexpression and phosphorylation of Stat3 plays a novel role in the excessive collagen deposition by fibroblasts, leading to fibrotic scars such as keloids. Inhibition of Stat3 expression by siRNA or Cucurbitacin I showed a corresponding decline in collagen expression (Figure 4b and c) , suggesting that collagen production may be regulated by Stat3 at the transcriptional level. Preliminary scanning of the promoter region of both collagen type I a1, COL1A1, and collagen type III a1, COL3A1, revealed some putative Stat3 binding sites (CP Lim and X Cao, unpublished) . It will be interesting to investigate whether Stat3 has a direct effect on the transcription of procollagen type I and III, the two collagens that are found to be highly synthesized in keloids (Abergel et al., 1985; Naitoh et al., 2001) .
The process of cutaneous wound healing can be arbitrarily divided into three phases -inflammation, tissue formation (re-epithelialization, formation of granulation tissue, neovascularization) and tissue remodeling, events that are governed by a well-orchestrated temporal and spatial secretion of various chemokines, cytokines and growth factors by different cell components (Singer and Clark, 1999; Werner and Grose, 2003) . Stat3 is a key molecule activated in response to most of these ligands. Here, we observed enhanced expression and phosphorylation of Stat3 in keloid tissues and fibroblasts, suggesting a lack of a stop signal or its downregulation, and/or an incessant stimulation by cytokines or growth factors. Indeed, some cytokines that activate Stat3 have been reported to be enhanced in keloid tissue such as IL-6 (Xue et al., 2000) . On the other hand, whether there is any mutation in Stat3 in keloid tissues that predisposes to its overexpression remains to be determined. As Stat3 is involved in all the different phases of wound healing, we speculate that normal regulation of Stat3 is required throughout the process, and dysregulation of Stat3 signaling will tip the balance towards impaired wound healing and fibrosis. Activation of Stat3 by proinflammatory cytokines also suggests a role of Stat3 in the progression of scarring at the inflammation phase, as fetal tissues that lack inflammation undergo perfect scarless wound healing, and scarring ensued in the presence of an acute inflammatory infiltrate (Yang et al., 2003) .
Owing to their autonomous nature, keloids have also been considered as benign tumors. Stat3, on the other hand, possesses oncogenic potential, as overexpression of a constitutively dimerized/active Stat3 mutant Figure 6 Increased cell migration in keloid fibroblasts (KFs) compared to normal fibroblasts (NFs). (a) Three NFs, NF2, NF4 and NF103, and three KFs, KF43, KF48 and KF107, were grown in 60 mm dishes until confluent, and treated with 10 mg/ml mitomycin C for 2 h, before a scratch wound was introduced using a yellow pipette tip. Cells were incubated for a further 14 h in normal growth media. Pictures were taken at 0 and 14 h after wounding. (b) Pictures from three non-overlapping fields from (a) were taken and cells migrated into the wound site were quantified. Data are presented as mean7s.d. *Po0.05 indicates KF43 vs NF4 and NF103, whereas **Po0.005 and ***Po0.001 refer to three NFs vs KF48 and KF107, respectively, by Student's t-test. (c) Cell migration was also examined using Transwell assay, performed in triplicates. KF48 cells were seeded in serum-free Dulbecco's modified Eagles's medium (DMEM) at the top of the insert with 10% fetal bovine serum (FBS)/DMEM as chemoattractant in the bottom chamber. Cells from three non-overlapping fields from each replicate that migrated from top to bottom of the insert after 48 h were counted and the mean of the triplicates7s.d. was presented in the graph. *Po0.001 and **Po0.005 indicate three NFs vs KF43, and KF48 and KF107, respectively, by Student's t-test.
(Stat3C) caused cellular transformation and tumor formation (Bromberg et al., 1999) , and Stat3 was shown to be essential for developing skin cancer in mice (Chan et al., 2004) . Recently, overexpression of Stat3C in A549 carcinoma cells followed by microarray analyses revealed that Stat3 regulated genes are common to both wound healing and cancer, including cell invasion/ migration, angiogenesis and remodeling of ECM, based on the concept that tumors are 'wounds that do not heal' (Dauer et al., 2005) . This supports our observation that hyperactive Stat3 plays a role in wound healing gone awry, as seen in keloids. However, there is still a distinct difference between wound healing and skin cancer, as cancer cells metastasize and scars do not.
In summary, we have shown for the first time a novel role of Stat3 in the pathogenesis of keloid scars.
Inhibitors of Stat3 expression or phosphorylation were able to suppress KF collagen production, cell proliferation and migration to a level comparable to NFs. Besides siRNA and Cucurbitacin I, the efficacy of other Stat3 inhibitors could additionally be explored, including other pharmacological agents such as Cucurbitacin Q, which is an analog of Cucurbitacin I and a selective Stat3 inhibitor (Sun et al., 2005) , STA-21 , Stat3 decoy oligonucleotide (Leong et al., 2003) , or phosphotyrosyl peptides (Turkson et al., 2001) , all of which either exhibited antitumor activity, increased apoptosis and inhibited proliferation or suppressed cell transformation of cancer-derived or v-Src-transformed cell lines. These potential cancer therapeutic agents that target the inhibition of Stat3 may also be useful for the prospective clinical treatment of keloid scars. (d) KF48 cells were pretreated with 10 mg/ml mitomycin C for 2 h, followed by either dimethyl sulfoxide (DMSO) or 1 mM Cucurbitacin I for 30 min, before cells were wounded using yellow pipette tips. Cells were further incubated in 10% fetal bovine serum (FBS)/ Dulbecco's modified Eagles's medium (DMEM) normal growth media, and pictures were taken at 0, 22 and 48 h after wounding. (e) Data represent mean7s.d. of cells migrated into wounding sites from three non-overlapping fields from (d). *Po0.001 by Student's ttest.
Materials and methods

Normal and keloid tissue/fibroblasts
Ethical approvals from the National University of Singapore Institutional Review Board and National Healthcare Group Domain Specific Review Boards, and informed consent from patients, were obtained before surgical excision of skin and keloid tissue. All patients had received no prior treatment for keloid lesions. A full history was taken and physical examination was performed in addition to color-slide photo documentation of all keloid lesions. The procedure for the isolation and culture of fibroblasts from skin specimens was as described previously (Lim et al., 2002) . Isolated fibroblasts were grown in Dulbecco's modified Eagles's medium (DMEM) containing 4500 mg/ml glucose, supplemented with 10% fetal bovine serum (FBS), 2 mM L-glutamine, 100 U/ml penicillin and 100 ng/ml streptomycin. Normal skin and keloid scar tissue, and normal and keloid-derived fibroblasts, used in this work are listed in Supplementary data.
For the isolation of tissue lysates for Western blot analysis, frozen tissue specimens were lysed in lysis buffer containing 20 mM Tris-HCl, pH 7.5, 1% Triton X-100, 100 mM NaCl, 0.5% Nonidet P-40 and 1 mg/ml protease inhibitor cocktail (Boehringer Mannheim, Germany). Equal amounts of proteins were resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis in Western blot analysis.
Antibodies and reagents
Polyclonal anti-phosphoTyr705 Stat3, monoclonal antiphosphoSer727 Stat3, anti-pJak1 (Tyr1022/1023), anti-pJak2 (Tyr1007/1008), anti-phosphoSrc (Tyr416), anti-phospho-EGFR (Tyr845) and anti-Bcl-X L antibodies were purchased from Cell Signaling Technology, whereas monoclonal pStat3 (B7) (sc-8059), polyclonal Stat3 (C-20) (sc-482), monoclonal cyclin D1 (sc-20044), anti-mouse IgG (sc-2025) and anti-rabbit IgG (sc-2027) antibodies were acquired from Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA). Monoclonal anti-Stat3 antibody was purchased from BD Transduction Laboratories (Lexington, KY, USA). Polyclonal anti-actin antibody and mitomycin C were purchased from Sigma (Saint Louis, MO, USA) and monoclonal anti-human collagen I, II, III was purchased from MONOSAN (Uden, Netherlands). AG 490 was obtained from Calbiochem (San Diego, CA, USA), whereas Cucurbitacin I was acquired from Galchimia (A Corun˜a, Spain).
Hematoxylin-eosin staining
Tissue sections were fixed with 4% paraformaldehyde in phosphate-buffered saline (PBS), embedded in paraffin and sectioned. Tissue sections were stained with hematoxylin for 5-8 min, washed with running water, quickly destained with acid ethanol containing 1% hydrochloric acid and 70% ethanol, washed with running water and counterstained with eosinethanol for 3-5 min. Tissue sections were then rehydrated by gradual immersion in 70, 80, 95 and 100% ethanol, cleared with xylene and finally mounted in entellan. Pictures were taken with Leica DM4000 B microscope.
Immunofluorescence
Cryosections were fixed with 4% paraformaldehyde in PBS for 15-30 min at room temperature, washed thrice with 0.1% Triton X-100 in PBS for 10 min each, and blocked with FDB (Fluorescence Dilution Buffer) containing 5% normal goat serum, 2% FBS, 2% bovine serum albumin, 1 mM CaCl 2 and 1 mM MgCl 2 in PBS. Tissue sections were washed as above and incubated for 1 h at room temperature, with primary antibody diluted 1:200 in FDB to 1 mg/ml for monoclonal pStat3 (B7), polyclonal Stat3 (C-20), anti-mouse IgG or anti-rabbit IgG antibodies. Tissue sections were washed again as described and incubated for 1 h at room temperature, with either FluoroLink Cy3-labeled goat anti-rabbit IgG (PA43004; Amersham Biosciences, Pistacaway, NJ, USA) or anti-mouse IgG-Cy3 (AP124C; Chemicon International, Tencala, CA, USA) diluted at 1:400 in FDB. Sections were washed again and mounted with Vectashield mounting medium containing 4,6-diamidino-2-phenylindole (DAPI) (H-1200; Vector Laboratories Inc., Burlingame, CA, USA). Pictures were taken with Leica DM4000 B microscope.
XTT proliferation assay Cells seeded at 3000 cells/well in 96-well plates and grown in normal growth conditions, or infected with retrovirus expressing Stat3 siRNAs, were assayed for proliferation using the XTT sodium 3 0 -[1-(phenylaminocarbonyl)-3,4-tetrazolium]-bis (4-methoxy-6-nitro) benzene sulfonic acid hydrate proliferation kit (Roche, Mannheim, Germany) according to the manufacturer's instructions. The readings were taken at 450 nm and referenced against 690 nm, 2 h after the addition of the XTT reagent. Each sample was performed at quadruplicates in two to three independent experiments. Data are presented as mean7s.d.
Migration assay
For migration assay using the scratch method, cells were grown to confluence and incubated with 10 mg/ml mitomycin C for 2 h, before a scratch wound was introduced using a yellow pipette tip. Cells were further incubated in normal growth media and pictures were taken at 0, 14, 15, 22 or 48 h after wounding. Three non-overlapping fields were captured by Axiovert 135 microscope from Zeiss (Jena, Germany) and cells migrated into the wound site were counted and presented as mean7s.d.
Migration assay was also performed using the Transwell 8.0 mM pore size polycarbonate membrane (Corning Inc., Acton, MA, USA). 1 Â 10 4 cells/well were seeded at the top of the insert in 0.2 ml serum-free DMEM, with 0.5 ml 10% FBS/DMEM in the bottom chamber as chemoattractant. After 24 h, cells were washed once in cold PBS, before fixing with 4% paraformaldehyde in PBS for 15 min at room temperature. Cells were permeabilized with 0.1% Triton X-100 in PBS for 3 min at room temperature, and stained with hematoxylin for 10 min at room temperature, followed by destaining with water thrice. Cells from the top of the inserts were removed by cotton swabs, and inserts were left to dry. The inserts were mounted onto slides and three non-overlapping fields of cells migrated to the bottom of the inserts were captured using Leica DM4000 B microscope.
Retroviral Stat3 short interfering RNA Four different targets against Stat3 (Genbank Accession number NM_139276) were selected and cloned into BglII and XhoI into pSUPER. retro.puro from OligoEngine, Seattle, WA, USA and sequenced. The four targets are named Stat3 siRNA 1 (nucleotides (nt) 461-480), Stat3 siRNA 2 (nt 1264-1283), Stat3 siRNA 3 (nt 364-383) and Stat3 siRNA 4 (nt 1662-1681). The corresponding primers with a 9-nt short hairpin in the middle (bold) are F1 5 0 -GATCCCCAGTCGAATGTT CTCTATCATTCAAGAGATGATAGAGAACATTCGACT TTTTTC-3 0 and R1 5 0 -TCGAGAAAAAAGTCGAATGTT CTCTATCATCTCTTGAATGATAGAGAACATTCGACT GGG-3 0 , F2 5 0 -GATCCCCGGCGTCCAGTTCACTACTA 0 . These vectors containing Stat3 siRNA or empty vector were transfected into 293T-based amphotropic packaging cell line (Phoenix-Ampho) for 7-9 h, and the amphotropic retroviruses were harvested 48 h later, pelleted to remove non-adherent cells and cellular debris, and filtered through a 0.45 mM cellulose acetate membrane. The KFs were infected overnight in the presence of 4 mg/ml polybrene, and replaced with fresh 10% FBS/DMEM the following day. Cells were assayed for Western blot 48 h after infection, or XTT cell proliferation or migration assay, which was performed by replating the cells into 8.0 mM Transwell membrane and fixed 24 h later as described above.
